AdvaMed lobbyist JC Scott to succeed Mark Merritt, who is leaving after 15 years pharmacy benefit managers group Scott Lobbyist JC Scott will become the next CEO of the Pharmaceutical Care Management Association following the departure of Mark Merritt, who has led the $21 million-revenue group for 15 years. Scott currently is chief advocacy officer and head of external affairs for the Advanced Medical Technology Association. He will begin his new role as PCMA's chief executive Oct. 15, leading a group embroiled in policy fights on drug pricing and, more recently, the opioid crisis. "JC is an exceptional choice with a tremendous record of accomplishments, both in the… Read More